Multiple sclerosis (MS) is a disease that affects the brain and spinal cord. It happens when the body’s immune system ...

FDA adds boxed warning to a multiple sclerosis drug, citing rare but severe risk. Today, the FDA issued a warning about the risk of anaphylaxis, a rare but life-threatening allergic reaction ...

Multiple sclerosis (MS) research has uncovered a potential ... diagnosed with MS may be at higher risk for developing more severe disability over time," explains Dr. Gonçalves.

Cataracts, a common eye condition characterized by clouding of the lens, often lead to blurred vision and, if left untreated, ...

Severe obesity in childhood and adolescence more than triples the risk of MS, and obesity treatment does not seem to reverse ...

Children who develop multiple sclerosis appear to fare better if they were exposed to safe amounts of summer sunshine as ...

Nov. 18, 2024 — Fampridine is currently used to improve walking ability in multiple sclerosis. A new study shows that it could also help individuals with reduced working memory, as seen in ...

The following is a summary of “Chronic graft-versus-host disease myelitis successfully treated with rituximab,” published in ...

The drug, glatiramer acetate, is approved to treat patients with relapsing forms of multiple sclerosis ... including severe rash or shock, which is a life-threatening condition.

a rare but severe allergic reaction associated with glatiramer acetate, a medication used to treat relapsing forms of multiple sclerosis (MS). Anaphylaxis can occur at any time during treatment ...

More information: Peripartum Mental Illness in Mothers With Multiple Sclerosis and Other Chronic Diseases in Ontario, Canada, Neurology (2025). DOI: 10.1212/WNL.0000000000210170 Journal ...